Provided by Tiger Trade Technology Pte. Ltd.

REVVITY INC

153.60
+0.30000.20%
Volume:2.23M
Turnover:342.91M
Market Cap:17.17B
PE:73.35
High:156.01
Open:153.03
Low:149.25
Close:153.30
52wk High:166.25
52wk Low:81.22
Shares:111.80M
Float Shares:102.00M
Volume Ratio:0.90
T/O Rate:2.19%
Dividend:0.28
Dividend Rate:0.18%
EPS(TTM):2.09
EPS(LYR):2.07
ROE:3.21%
ROA:2.37%
PB:2.38
PE(LYR):74.25

Loading ...

Weekly Winners | Bio-Techne Soars 23%; AbbVie Surges 17%; United Airlines Jumps 15%; Corning, Merck Gain 13%

Tiger Newspress
·
Jun 28

Revvity Price Target Announced at $115.00/share by Bernstein

Dow Jones
·
Jun 26

Revvity up over 7%, on Pace for Largest Percent Increase Since May 2025

Dow Jones
·
Jun 26

Movement Alert|REVVITY INC Rises 7.37% in Regular Trading, Trading at $113.405

Market Focus
·
Jun 26

Revvity Inc. Stock Rallies 5.7%, Outperforms Peers

Dow Jones
·
Jun 25

Movement Alert|Revvity Rises 6.14% in Regular Trading, Trading at $105.97

Market Focus
·
Jun 25

Revvity launches Signals AI framework

TIPRANKS
·
Jun 22

Revvity Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jun 13

Revvity Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 09

How Investors May Respond To Revvity (RVTY) Divesting Its China Immunodiagnostics Business

Simply Wall St.
·
Jun 09

Revvity Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 05

Revvity Coverage Assumed by Wolfe Research at Peer Perform

Dow Jones
·
Jun 02

Revvity Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 02

Revvity assumed with a Peer Perform at Wolfe Research

TIPRANKS
·
Jun 02

Revvity Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 30

Revvity Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
May 21

Revvity Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
May 16

Revvity Inc. Stock Slides 4.3%, Underperforms Peers

Dow Jones
·
May 14

Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution

THOMSON REUTERS
·
May 13

Revvity Q1 FY26 income from continuing operations slips 2% to $40.9 million; revenue rises 7% to $711.1 million

Reuters
·
May 13